HOME >> BIOLOGY >> NEWS
Medical research scientists make ethical value judgments in research

NEW YORK (May 14, 2007) -- Medical research scientists in public health and other areas routinely make ethical value judgments, even if they're not aware of it, according to a new Weill Cornell Medical College research study. And not only do these judgments not lead to bias necessarily, but they can make for better research.

Published in the current issue of European Journal of Epidemiology, the paper finds that the framing of the research question, identification of the problem, as well as the design and methodology of the study are all subject to value judgments by investigators.

To illustrate this point, the study focuses on how value judgments are made in epidemiological research of racial health disparities.

"Epidemiologists must endorse particular public policy aims of the research in order to make methodological decisions throughout the research process. In the case of research into racial disparities, the researcher decides how to define race -- whether by genetic markers or by census data. Both definitions are valid on their own, but in deciding which one to use, the scientist makes value assumptions about which would best promote the social aims of the research, such as eliminating racial disparities," says Dr. Inmaculada de Melo-Martn, the study's co-author and associate professor in the Division of Medical Ethics in the Department of Public Health at Weill Cornell Medical College.

"Also, scientists make value judgments in deciding which areas of research to pursue. For example, if the recommendations likely to result from additional genetic research are already part of standard medical practice, or if the new drugs resulting from genetic research would likely be too expensive for minority groups, then genetic research may not be the most effective way of trying to decrease racial health disparities," notes Dr. de Melo-Martn.

"In fact, many medical research scientists make these value judgments without
'"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
14-May-2007


Page: 1 2

Related biology news :

1. Ossurs PROPRIO FOOT takes the Gold 2007 Medical Design Excellence Award
2. Innovative smallpox vaccine research study to be conducted at Case Medical Center
3. Vitamin extends life in yeast, Dartmouth Medical School researchers find
4. Ossurs Proprio Foot walks away with 2007 Medical Design Excellence Award
5. University of Minnesotas 6th annual Design of Medical Devices Conference to be held April 17-19
6. Columbia University Medical Center awarded $3 million to drive Alzheimers genetics research
7. Burnham Institute for Medical Research announces affiliation with UC Santa Barbara
8. Yale scientist honored with Keio University Medical Science Prize
9. American College of Medical Genetics -- 2007 Annual Clinical Genetics Meeting Announcement
10. Breast Cancer Month story tips from Georgetown University Medical Center
11. Columbia University Medical Center receives major new NIH Clinical Science investment funds

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ...
Breaking Biology Technology:
Cached News: